TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05780710: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lower

Sponsor: Aktiia SA · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 35 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,905,600

Rescue Site Savings

+$4,548,400

Unlock Full NCT05780710 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05780710 Rescue Dossier →